Michael Morr
13Patents
5h-index
18Co-inventors
63Inventor score
Filing activity: Oct 23, 1980 → Dec 28, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4343735A | Process for the purification of interferon | Chemistry; Metallurgy | 29 | Expired |
| US9597391B2 | Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 21 | Active |
| US4416830A | Polyether phosphoric acids or esters | Chemistry; Metallurgy | 9 | Expired |
| US7316996B2 | Bisacyloxypropylcysteine conjugates and the use thereof | Human Necessities | 9 | Expired |
| US8119689B2 | Adjuvants on the basis of bisacyloxypropylcystene conjugates and derivatives and their uses in pharmaceutical compositions | Human Necessities | 6 | Active |
| US4689407A | 2-deoxy-3-phosphonylmethyl nucleosides | Chemistry; Metallurgy | 4 | Expired |
| US4845222A | Pyocyanine derivatives and process for their manufacture | Chemistry; Metallurgy | 3 | Expired |
| US5776363A | Compounds having side chains with multiple methyl branches and their use in liquid-crystal mixtures | Chemistry; Metallurgy | 3 | Expired |
| US5670049A | Nucleotide-containing sorbent for affinity chromatography | Physics | 3 | Expired |
| US8053417B2 | Hexosylceramides as adjuvants and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US8257734B2 | PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions | Emerging Cross-Sectional Technologies | 1 | Active |
| US10918733B2 | Lipopeptide- and lipoprotein-conjugates and its use | Human Necessities | 0 | Active |
| US8211463B2 | Use of glycolipids as adjuvants | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.